Tim-3 Suppression Combined With TLR3 Activation Enhances Antiviral Immune Response in Patients With Chronic HCV Infection

Journal of International Medical Research - United Kingdom
doi 10.1177/0300060516647548
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Pretreatment Serum Alpha Fetoprotein and Its Relation to Sustained Virologic Response in Patients With Chronic HCV Infection Treated With Direct-Acting Antiviral Therapy

Medical Journal of Viral Hepatitis
2020English

Effects of Antiviral Therapy on the Cellular Immune Response in Patients With Chronic Hepatitis B

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2014English

Interleukin-35 Suppresses Antiviral Immune Response in Chronic Hepatitis B Virus Infection

Frontiers in Cellular and Infection Microbiology
MedicineInfectious DiseasesImmunologyMicrobiology
2017English

Induction of T-Cell Immune Response in Chronic HCV-Infected Patients With Underlying Dendritic Cell Immunotherapy

Medical Immunology (Russia)
AllergyImmunology
2017English

Estimation of Serum Leptin Level in Egyptian Patients With Chronic HCV After Antiviral Treatment

Journal of Gastroenterology and Hepatology Research
HepatologyGastroenterology
2015English

Immunization With Universal Influenza Vaccine Enhances Immune Response to Subsequent Infection

Russian Journal of Infection and Immunity
Infectious DiseasesAllergyImmunology
2019English

TLR3-TRIF Pathway Activation by Neospora Caninum RNA Enhances Infection Control in Mice

Infection and Immunity
ParasitologyInfectious DiseasesImmunologyMicrobiology
2019English

Reduction of Immune Activation With Chloroquine Therapy During Chronic HIV Infection

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2010English

Tim-3 Enhances FcεRI-proximal Signaling to Modulate Mast Cell Activation

Journal of Experimental Medicine
MedicineAllergyImmunology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy